Literature DB >> 12600696

Involvement of calcitonin gene-related peptide in the depressor effects of losartan and perindopril in rats.

Xu-Ping Qin1, Feng Ye, Duan-Fang Liao, Yuan-Jian Li.   

Abstract

Previous investigations have indicated that calcitonin gene-related peptide (CGRP) plays an important role in the regulation of cardiovascular function, and that the development of hypertension may be related to the reduction of sensory vasodilator nerve actions. In the present study, we examined the effect of perindopril, an angiotensin-converting enzyme inhibitor, and losartan, an angiotensin II receptor antagonist, on the plasma level and synthesis of CGRP in 2 kidneys, 1-clip hypertensive rats (2K1C, Goldblatt). In the hypertension group, systolic blood pressure and mean artery pressure were raised, and the level of CGRP in plasma was slightly raised compared with control groups. Chronic treatment with losartan or perindopril significantly increased the plasma concentration of CGRP and the expression of CGRP mRNA in dorsal root ganglia in the 2K1C, Goldblatt hypertensive rats. These results suggest that the 2K1C, Goldblatt hypertensive model has a compensatory increase of sensory nerve actions, and that the depressor effects of perindopril or losartan may be related to stimulation of the synthesis and release of CGRP in the 2K1C, Goldblatt hypertensive rats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12600696     DOI: 10.1016/s0014-2999(03)01370-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Calcitonin gene-related peptide released from endothelial progenitor cells inhibits the proliferation of rat vascular smooth muscle cells induced by angiotensin II.

Authors:  Li Fang; Mei-Fang Chen; Zhi-Lin Xiao; Yin Liu; Guo-Long Yu; Xiao-Bin Chen; Xiu-Mei Xie
Journal:  Mol Cell Biochem       Date:  2011-05-21       Impact factor: 3.396

2.  Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis.

Authors:  Bo Wang; Radko Komers; Rosemarie Carew; Catherine E Winbanks; Bei Xu; Michal Herman-Edelstein; Philip Koh; Merlin Thomas; Karin Jandeleit-Dahm; Paul Gregorevic; Mark E Cooper; Phillip Kantharidis
Journal:  J Am Soc Nephrol       Date:  2011-11-17       Impact factor: 10.121

3.  Involvement of prolylcarboxypeptidase in the effect of rutaecarpine on the regression of mesenteric artery hypertrophy in renovascular hypertensive rats.

Authors:  Xu-Ping Qin; Si-Yu Zeng; Hai-Hong Tian; Shui-Xiu Deng; Jun-Fang Ren; Yuan-Bin Zheng; Dai Li; Yuan-Jian Li; Duan-Fang Liao; Shi-You Chen
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-10-31       Impact factor: 2.557

Review 4.  Pathophysiology and therapeutic possibilities of calcitonin gene-related peptide in hypertension.

Authors:  I Márquez-Rodas; F Longo; R P Rothlin; G Balfagón
Journal:  J Physiol Biochem       Date:  2006-03       Impact factor: 5.080

5.  Evidence That ADAM17 Mediates the Protective Action of CGRP against Angiotensin II-Induced Inflammation in Vascular Smooth Muscle Cells.

Authors:  Si-Yu Zeng; Li Yang; Chen-Liang Hong; Hui-Qin Lu; Qiu-Jiang Yan; Yan Chen; Xu-Ping Qin
Journal:  Mediators Inflamm       Date:  2018-06-12       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.